Septerna (SEPN) Profit After Tax (2023 - 2026)
Septerna's quarterly Profit After Tax came in at -$8.6 million in Q1 2026, up 59.78% year-on-year from -$5.4 million in Q1 2025, and up 20.03% quarter-over-quarter from -$10.8 million in Q4 2025.
Septerna has reported Profit After Tax for 4 years, with the latest figure at -$8.6 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax rose 59.78% year-over-year to -$8.6 million; the trailing twelve-month figure through Mar 2026 stood at -$36.1 million (up 54.4% YoY), and the FY2025 full-year result was -$48.9 million, up 31.89% from the prior year.
- Profit After Tax for Q1 2026 stood at -$8.6 million, up from -$10.8 million in the prior quarter.
- The five-year high for Profit After Tax was $34.9 million in Q4 2023, with the low at -$24.8 million in Q2 2025.
- Average Profit After Tax over 4 years is -$9.6 million, with a median of -$14.1 million recorded in 2024.
- Year-over-year, Profit After Tax slumped 159.23% in 2024 and surged 139.82% in 2025.
- Tracing SEPN's Profit After Tax over 4 years: stood at $34.9 million in 2023, then sank by 159.23% to -$20.7 million in 2024, then soared by 47.75% to -$10.8 million in 2025, then increased by 20.03% to -$8.6 million in 2026.
- The last three Profit After Tax figures came in at -$8.6 million (Q1 2026), -$10.8 million (Q4 2025), and $8.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Septerna | 1.34 Bn | 1.34 Bn | - | -8.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.64 Mn |
| Dec 31, 2025 | -10.80 Mn |
| Sep 30, 2025 | 8.17 Mn |
| Jun 30, 2025 | -24.84 Mn |
| Mar 31, 2025 | -21.48 Mn |
| Dec 31, 2024 | -20.67 Mn |
| Sep 30, 2024 | -20.52 Mn |
| Jun 30, 2024 | -16.51 Mn |
| Mar 31, 2024 | -14.10 Mn |
| Dec 31, 2023 | 34.89 Mn |
| Sep 30, 2023 | -10.95 Mn |